Alexion Pharmaceuticals (United States)

Alexion Pharmaceuticals (United States)

Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alexion Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

61%


Total
Publications

979


Total Open
Publications

593


Total
Citations

35K


Open Access
Percentage

61%


Total
Publications

979


Total Open
Publications

593


Total
Citations

35K

Wikipedia

Website

download

Breakdown

22% 33% 6% 39%

Publisher Open

22%

Both

33%

Other Platform Open

6%

Closed

39%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

35%OA Journal

OA Journal 35%

187

Hybrid 37%

197

No Guarantees 28%

153

Other Platform Open

Domain 85%

319

Institution 26%

97

Other Internet 9%

33

Preprint 6%

22

Public 5%

17

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
315
Europe PMC
Domain
121
Radboud University - Radboud Repository
Institution
20
Ghent University - Ghent University Academic Bibliography
Institution
20
Semantic Scholar
Public
11
Figshare
Public
11
Research Square
Preprint
10
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
10
Erasmus University Rotterdam - EUR Research Repository
Institution
8
DOI
Other Internet
8
1 / 10

Data updated 7 April 2025

Share

Share

Share